- Home
- NIXX vs ESLA Comparison
NIXX vs ESLA Comparison
Compare NIXX & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- ESLA
- Stock Information
- Founded
- NIXX 2010
- ESLA 2021
- Country
- NIXX United States
- ESLA United States
- Employees
- NIXX N/A
- ESLA N/A
- Industry
- NIXX
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIXX
- ESLA Health Care
- Exchange
- NIXX NYSE
- ESLA Nasdaq
- Market Cap
- NIXX 30.1M
- ESLA 35.5M
- IPO Year
- NIXX N/A
- ESLA N/A
- Fundamental
- Price
- NIXX $2.31
- ESLA $1.07
- Analyst Decision
- NIXX
- ESLA Strong Buy
- Analyst Count
- NIXX 0
- ESLA 1
- Target Price
- NIXX N/A
- ESLA $16.00
- AVG Volume (30 Days)
- NIXX 219.6K
- ESLA 518.6K
- Earning Date
- NIXX 05-20-2025
- ESLA 06-17-2025
- Dividend Yield
- NIXX N/A
- ESLA N/A
- EPS Growth
- NIXX N/A
- ESLA N/A
- EPS
- NIXX N/A
- ESLA N/A
- Revenue
- NIXX $1,786,387.00
- ESLA N/A
- Revenue This Year
- NIXX N/A
- ESLA $101.09
- Revenue Next Year
- NIXX N/A
- ESLA N/A
- P/E Ratio
- NIXX N/A
- ESLA N/A
- Revenue Growth
- NIXX 54.16
- ESLA N/A
- 52 Week Low
- NIXX $1.35
- ESLA $0.63
- 52 Week High
- NIXX $8.50
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- ESLA 55.18
- Support Level
- NIXX N/A
- ESLA $0.78
- Resistance Level
- NIXX N/A
- ESLA $1.18
- Average True Range (ATR)
- NIXX 0.00
- ESLA 0.10
- MACD
- NIXX 0.00
- ESLA 0.00
- Stochastic Oscillator
- NIXX 0.00
- ESLA 71.28
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.